Intolerância ao exercício em pacientes com doença pulmonar obstrutiva crônica
Palabras clave:
Doença pulmonar obstrutiva crônica, Reabilitação, Tolerância ao exercícioResumen
A doença pulmonar obstrutiva crônica é uma doença irreversível, de elevada incidência e alto custo para os serviços públicos e privados de saúde. Essa doença restringe a capacidade física do indivíduo, o que contribui para hospitalizações frequentes e elevada mortalidade. O objetivo deste artigo é descrever as características da doença pulmonar obstrutiva crônica e os principais fatores que limitam a tolerância ao exercício nessa população. A intolerância ao exercício reduz a capacidade de pacientes com doença pulmonar obstrutiva crônica em realizarem suas atividades de vida diária, favorecendo o desenvolvimento de depressão, isolamento social e piora da qualidade de vida, entre outras complicações. Atualmente, as evidências científicas suportam a necessidade de que esses pacientes sejam submetidos a programas de reabilitação pulmonar, que incluem, entre outras atividades, a prática de exercício físico. Entretanto, para a compreensão da intervenção e obtenção de resultados mais efetivos, é fundamental o entendimento das alterações respiratórias e sistêmicas observadas na doença pulmonar obstrutiva crônica, assim como as razões que levam à inatividade física.
Descargas
Citas
Gosselink R, Troosters T, Decramer M. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2000; 20(6) 353-60.
Palange P, Ward SA, Carlsen K-H, Casaburi R, Gallagher CG, Gosselink R, et ai. Recommendations on the use of exercise testing in clinicai practice. Eur Respir J. 2007; 29(1):185-209.
Dourado VZ, Tanni SE, Vale SA, Faganello MM, Sanchez FF, Godoy 1. Manifestações sistêmicas na doença pulmonar obstrutiva crônica. J Bras Pneumol. 2006; 32(2):161-71
li Consenso Brasileiro sobre Doença Pulmonar Obstrutiva Crônica - DPOC. Avaliações clínicas na evolução da DPOC: qualidade de vida, estado nutricional, sono e capacidade de exercício. J Bras Pneumol. 2004; 30(Supl 5) s1-s42
Rodrigues SL, Viegas CAA, Lima T. Efetividade da reabilitação pulmonar como tratamento coadjuvante da doença pulmonar obstrutiva crônica. J Pneumol. 2002; 28(2):65-70.
Marcus BH, Williams DM, Dubbert PM, Sallis JF, King AC, Yancey AK, et ai. Physical activity intervention studies: what we know and what we need to know. Circulation. 2006; 114(24):2739-52.
Steiner MC, Morgan MD. Enhancing physical performance in chronic obstructive pulmonary disease. Thorax. 2001; 56(1):73-7.
American Thoracic Society e European Respiratory Society, 2004. Standarrds for the diagnosis and management of patients with COPD. [cited 2008 Oct] Available from: <http://www.copd-ats-ers.org>.
Pierson DJ. New international guidelines for chronic obstructive pulmonary disease. Resp Care. 2001; 46(8):768-71.
Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004; 364(9435):709-21.
Dhand R. Ventilator graphics and respiratory mechanics in the patient with obstructive lung disease. Respir Care. 2005; 50(2):246-59
Buffels J, Degryse J, Heyrman J. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO study. Chest. 2004; 125(4):1394-9.
Diaz-Lobato S, Mayoralas S. Underuse of spirometry in primary care. Chest. 2004; 126(5):1712-3.
Coussa ML, Guérin C, Eissa NT. Partitioning of work of breathing in mechanically ventilated COPD patients. J Appl Physiol. 1993; 75(4):1711-9.
Calverley PMA, Koulouris NG. Flow limitation and dynamic hyperinsuflation: key concepts in modem respiratory physiology. Eur Respir J. 2005; 25(1): 186-99.
Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effects of salbutamol on dynamic hiperinsuflation in chronic obstructive pulmonary disease. Eur Respir J. 1998; 12(4):799-804.
Blanch L, Bernabé F, Lucangelo U. Measurement of air trapping, intrinsic positive end-expiratory pressure, and dynamic hyperinflation in mechanically ventilated patients. Respir Care. 2005; 50(1):110-23.
O'Donoghue FJ, Catcheside PG, Jordan AS, Bersten AD, McEvoy RD. Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD. Thorax. 2002; 57(6):533-9.
Casanova C, Cote C, Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, et ai. lnspiratory to total lung capacity ratio predicts mortality in patients with chronic obstrutive pulmonary disease. Am J Respir Crit Care Med. 2005; 171(6):591-7.
Dykstra BJ, Scanlon PD, Kester MM, Beck KC, Enright PL. Lung volumes in 4,774 patients with obstructive lung disease. Chest. 1999; 115(1):68-74.
Ferguson GT. Why does the lung hyperinflate? Proc Am Thorac Soe. 2006; 3(2):176-9.
Pepe AE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis. 1982; 126(1):166-70.
Haluszka J, Chartrand DA, Grassino AE, Milic-Emilli J. lntrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1990; 141(5):1194-7.
Tobin MJ, Lodato RF. PEEP, auto-PEEP, and waterfalls. Chest. 1989; 96(3):449-51.
Marini JJ. Should PEEP be used in airflow obstruction? Am Rev Respir Dis. 1989; 140(1):1-3.
Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001; 56(11):880-7.
Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005; 60(11):925-31.
Killian KJ, LeBlanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 1992; 146(4):935-40.
Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996; 153(3): 976-80.
Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ, et ai. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 168(5):562-7.
Parekh PI, Blumenthal JA, Babyak MA, Merrill K, Carney RM, Davis RD, et ai. Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest. 2003; 124(4):1682-8.
Janson C, Bjornsson E, Hetta J, Boman G. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med. 1994; 149(4): 930-4.
O'Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev. 2006; 15(100):61-7.
Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et ai. American thoracic society documents: american thoracic society/european respiratory society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006; 173(12):1390-413.
Díaz O, Vil/atranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emili J, et ai. Breathing pattern and gas exchange at peak exercise in COPO patients with and without tidal flow limitation at rest Eur Respir J. 2001; 17(6): 1120-7.
Tangri S, Wolf CR. The breathing pattern in Chronic Obstructive lung Disease during the performance of some common daily activities. Chest 1973; 63(1): 126-7.
O'Donnel DE, Revi li SM, Webb KA. Dynamic Hyperinflation and exercise intolerance in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2001; 164(5):770-7.
Somfay A, Porszasz J, Lee SM, Casaburi R. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPO patients. Chest 2002; 121(2):393-400.
World Health Organization. Global lnitiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease updated. Washington (DC): National lnstitutes of Health; 2004.
Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, et ai. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 158(2):629-34.
Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, et ai. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sei Sports Exerc. 1998; 30(10):1467-74.
Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPO. Am J Respir Crit Care Med. 1996; 153(1):288-93.
AIlaire J, Maltais F, Doyon JF, Noel M, LeBlanc P, Carrier G, et ai. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPO. Thorax. 2004; 59(8):673-8
A Statement of the American Thoracic Society and European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 159(4):2-40.
Powers SK, Howley ET. Bioenergética. ln: Powers SK, Howley ET, editores. Fisiologia do exercício: teoria e aplicação ao condicionamento e ao desempenho. 3a. ed. São Paulo: Manole; 2000.
Levine S, Gregory C, Nguyen T, Shrager J, Kaiser L, Rubinstein N, et ai. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPO. J Appl Physiol. 2002; 92(3):1205-13.
Doucet M, Debigare R, Joanisse DR, Cote C, Leblanc P, Gregoire J, et ai. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPO. Eur Respir J. 2004; 24(6):971-9.
Rochester DF, Braun NM. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis .1985; 132(1):42-7.
Perez T, Becquart LA, Stach B, Wallaert B, Tonnel AB. lnspiratory muscle strength and endurance in steroid-dependent asthma. Am J Respir Crit Care Med. 1996; 153(2):610-5.
